Mintox
NDC Package 17856-6764-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Mintox is •shake well before using•only use the dose cup provided•adults and children 12 years and older: take 10 mL to 20 mL four times a day or as directed by a physician•do not take more than 80 mL in 24 hours or use the maximum dosage for more than 2 weeks•children under 12 years: consult a physician. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-6764 and is authorized under FDA application part332.

Identification & Billing

NDC Package Code
17856-6764-1
Package Description
50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 30 mL in 1 CUP, UNIT-DOSE
Product Code
17856-6764
11-Digit Billing Format
17856676401
RxNorm Crosswalk
  • RxCUI: 210037 - Mintox 200 MG / 200 MG / 20 MG in 5 mL Oral Suspension
  • RxCUI: 210037 - aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension [Mintox Plus]
  • RxCUI: 210037 - Mintox Plus (aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 20 MG) per 5 ML Oral Suspension
  • RxCUI: 210037 - Mintox Plus (aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML) Oral Suspension
  • RxCUI: 307746 - aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 20 MG in 5 mL Oral Suspension

Clinical Specifications

Proprietary Name
Mintox
Dosage Form
-
Usage Information
•shake well before using•only use the dose cup provided•adults and children 12 years and older: take 10 mL to 20 mL four times a day or as directed by a physician•do not take more than 80 mL in 24 hours or use the maximum dosage for more than 2 weeks•children under 12 years: consult a physician

Regulatory & Marketing

Labeler Name
Atlantic Biologicals Corp.
FDA Application #
part332
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
05-21-2019
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17856-6764-1 identifies a specific commercial package of 50 cup, unit-dose in 1 box, unit-dose / 30 ml in 1 cup, unit-dose of Mintox, labeled by Atlantic Biologicals Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Atlantic Biologicals Corp. on May 21, 2019. The current certification is valid through December 31, 2022.

How is this Atlantic Biologicals Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856676401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
17856-6764-1
11-Digit CMS (5-4-2)
17856-6764-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.